Conn Avi Daniel 4

What Happened

• Avi Conn (listed as Conn Avi Daniel), Chief Financial Officer of Tvardi Therapeutics (TVRD), received a derivative equity award on Jan 29, 2026: an option covering 45,000 shares. The grant was recorded at $0.00 on the Form 4 (a grant/award of a derivative, not an immediate cash purchase).

Key Details

• Transaction date: January 29, 2026; Report filed: February 2, 2026.
• Transaction type: A = Award/Grant (derivative option), 45,000 shares, $0.00 reported on grant.
• Vesting: Shares subject to the option vest in equal monthly installments over 48 months beginning January 29, 2026 (requires continuous service).
• Shares owned after the transaction: not specified in the provided excerpt of the filing.
• No 10b5-1 plan, tax withholding, or cashless exercise noted in the filing excerpt; filing does not indicate lateness.

Context

• This was a grant of an option (a derivative award), not an exercised purchase or sale—Conn did not receive immediately tradeable shares or proceeds. Vesting over four years means the award converts into exercisable rights gradually, subject to continued service.
• Such grants are common as compensation for executives and do not by themselves signal an immediate buy or sell in the market.